{"id":"https://openalex.org/W3126973301","doi":"https://doi.org/10.7150/jca.51845","title":"Efficacy of second-line treatments for patients with advanced human epidermal growth factor receptor 2 positive breast cancer after trastuzumab-based treatment: a systematic review and bayesian network analysis","display_name":"Efficacy of second-line treatments for patients with advanced human epidermal growth factor receptor 2 positive breast cancer after trastuzumab-based treatment: a systematic review and bayesian network analysis","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3126973301","doi":"https://doi.org/10.7150/jca.51845","mag":"3126973301","pmid":"https://pubmed.ncbi.nlm.nih.gov/33613756","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7890320"},"language":"en","primary_location":{"id":"doi:10.7150/jca.51845","doi":"https://doi.org/10.7150/jca.51845","is_oa":true,"landing_page_url":"https://doi.org/10.7150/jca.51845","pdf_url":"https://www.jcancer.org/v12p1687.pdf","source":{"id":"https://openalex.org/S200072998","display_name":"Journal of Cancer","issn_l":"1837-9664","issn":["1837-9664"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317973","host_organization_name":"Ivyspring International Publisher","host_organization_lineage":["https://openalex.org/P4310317973"],"host_organization_lineage_names":["Ivyspring International Publisher"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.jcancer.org/v12p1687.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100405374","display_name":"Fei Chen","orcid":"https://orcid.org/0000-0002-1679-9932","observed_orcids":["https://orcid.org/0000-0002-1679-9932"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fei Chen","raw_affiliation_strings":["Cancer Center, the First Hospital of Jilin University, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, the First Hospital of Jilin University, Changchun, China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068399557","display_name":"Naifei Chen","orcid":"https://orcid.org/0000-0002-8625-5121","observed_orcids":["https://orcid.org/0000-0002-8625-5121"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Naifei Chen","raw_affiliation_strings":["Cancer Center, the First Hospital of Jilin University, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, the First Hospital of Jilin University, Changchun, China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100649138","display_name":"Zheng Lv","orcid":"https://orcid.org/0000-0002-1872-0036","observed_orcids":["https://orcid.org/0000-0002-1872-0036"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zheng Lv","raw_affiliation_strings":["Cancer Center, the First Hospital of Jilin University, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, the First Hospital of Jilin University, Changchun, China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100623758","display_name":"Lingyu Li","orcid":"https://orcid.org/0000-0001-6788-8620","observed_orcids":["https://orcid.org/0000-0001-6788-8620"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lingyu Li","raw_affiliation_strings":["Cancer Center, the First Hospital of Jilin University, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, the First Hospital of Jilin University, Changchun, China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036233749","display_name":"Jiuwei Cui","orcid":"https://orcid.org/0000-0001-6496-7550","observed_orcids":["https://orcid.org/0000-0001-6496-7550","https://orcid.org/0000-0002-1664-9491"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jiuwei Cui","raw_affiliation_strings":["Cancer Center, the First Hospital of Jilin University, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, the First Hospital of Jilin University, Changchun, China","institution_ids":["https://openalex.org/I4210125137"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036233749"],"corresponding_institution_ids":["https://openalex.org/I4210125137"],"apc_list":{"value":2000,"currency":"AUD","value_usd":1337},"apc_paid":{"value":2000,"currency":"AUD","value_usd":1337},"fwci":0.1817,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.21106281,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"12","issue":"6","first_page":"1687","last_page":"1697"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/trastuzumab-resistance","display_name":"trastuzumab resistance","score":0.8999999761581421},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pyrotinib","display_name":"pyrotinib","score":0.718999981880188},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9430000185966492},{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":0.8939999938011169},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9359999895095825},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.921999990940094},{"id":"https://openalex.org/keywords/neratinib","display_name":"neratinib","score":0.8489999771118164},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.9539999961853027},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.6840000152587891},{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.7829999923706055},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9589999914169312},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.32499998807907104}],"concepts":[{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.9570431709289551},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8848781585693359},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.8647396564483643},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.7579600811004639},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7202864289283752},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7095258831977844},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.6955925226211548},{"id":"https://openalex.org/C2779413316","wikidata":"https://www.wikidata.org/wiki/Q6995920","display_name":"Neratinib","level":5,"score":0.6749110221862793},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6594876050949097},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5808274149894714},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4668930768966675},{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.43534958362579346},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.328549861907959},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.2432556450366974},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15328830480575562},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.10345563292503357},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.09393376111984253},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.07640951871871948}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7150/jca.51845","doi":"https://doi.org/10.7150/jca.51845","is_oa":true,"landing_page_url":"https://doi.org/10.7150/jca.51845","pdf_url":"https://www.jcancer.org/v12p1687.pdf","source":{"id":"https://openalex.org/S200072998","display_name":"Journal of Cancer","issn_l":"1837-9664","issn":["1837-9664"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317973","host_organization_name":"Ivyspring International Publisher","host_organization_lineage":["https://openalex.org/P4310317973"],"host_organization_lineage_names":["Ivyspring International Publisher"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7890320","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7890320","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Cancer","raw_type":"Text"},{"id":"pmid:33613756","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33613756","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7150/jca.51845","doi":"https://doi.org/10.7150/jca.51845","is_oa":true,"landing_page_url":"https://doi.org/10.7150/jca.51845","pdf_url":"https://www.jcancer.org/v12p1687.pdf","source":{"id":"https://openalex.org/S200072998","display_name":"Journal of Cancer","issn_l":"1837-9664","issn":["1837-9664"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317973","host_organization_name":"Ivyspring International Publisher","host_organization_lineage":["https://openalex.org/P4310317973"],"host_organization_lineage_names":["Ivyspring International Publisher"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[{"id":"https://openalex.org/G1843934894","display_name":null,"funder_award_id":"20190303146SF","funder_id":"https://openalex.org/F4320327282","funder_display_name":"Department of Science and Technology of Jilin Province"},{"id":"https://openalex.org/G443485259","display_name":null,"funder_award_id":"81672275","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G4977592080","display_name":null,"funder_award_id":"20180101009JC","funder_id":"https://openalex.org/F4320327282","funder_display_name":"Department of Science and Technology of Jilin Province"},{"id":"https://openalex.org/G6946973684","display_name":null,"funder_award_id":"2018SCZWSZX-010","funder_id":"https://openalex.org/F4320327282","funder_display_name":"Department of Science and Technology of Jilin Province"},{"id":"https://openalex.org/G7208851605","display_name":null,"funder_award_id":"20170622011JC","funder_id":"https://openalex.org/F4320327282","funder_display_name":"Department of Science and Technology of Jilin Province"},{"id":"https://openalex.org/G8240331401","display_name":null,"funder_award_id":"81874052","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320322174","display_name":"People's Government of Jilin Province","ror":"https://ror.org/02fzqav45"},{"id":"https://openalex.org/F4320327282","display_name":"Department of Science and Technology of Jilin Province","ror":"https://ror.org/049x38272"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3126973301.pdf","grobid_xml":"https://content.openalex.org/works/W3126973301.grobid-xml"},"referenced_works_count":69,"referenced_works":["https://openalex.org/W1505367831","https://openalex.org/W1617328014","https://openalex.org/W1902576439","https://openalex.org/W1964808503","https://openalex.org/W1968590850","https://openalex.org/W1974685860","https://openalex.org/W1981701117","https://openalex.org/W1984007340","https://openalex.org/W1989078916","https://openalex.org/W1993134078","https://openalex.org/W2000798782","https://openalex.org/W2010699829","https://openalex.org/W2012784647","https://openalex.org/W2040557955","https://openalex.org/W2059411043","https://openalex.org/W2091808438","https://openalex.org/W2101824720","https://openalex.org/W2101979288","https://openalex.org/W2103808574","https://openalex.org/W2110444464","https://openalex.org/W2116355318","https://openalex.org/W2122080125","https://openalex.org/W2123591186","https://openalex.org/W2133540186","https://openalex.org/W2137086207","https://openalex.org/W2137228442","https://openalex.org/W2141546964","https://openalex.org/W2144625636","https://openalex.org/W2148479421","https://openalex.org/W2156677665","https://openalex.org/W2159967578","https://openalex.org/W2162794726","https://openalex.org/W2170241131","https://openalex.org/W2251611718","https://openalex.org/W2323398285","https://openalex.org/W2403969311","https://openalex.org/W2443444708","https://openalex.org/W2577651608","https://openalex.org/W2609953159","https://openalex.org/W2613098450","https://openalex.org/W2614773797","https://openalex.org/W2616596696","https://openalex.org/W2801864212","https://openalex.org/W2803163286","https://openalex.org/W2806388890","https://openalex.org/W2912923142","https://openalex.org/W2914643394","https://openalex.org/W2945268366","https://openalex.org/W2947067095","https://openalex.org/W2947573449","https://openalex.org/W2947964130","https://openalex.org/W2969017474","https://openalex.org/W2969604985","https://openalex.org/W2990398119","https://openalex.org/W2995808512","https://openalex.org/W2999417355","https://openalex.org/W3006600886","https://openalex.org/W3007580854","https://openalex.org/W3012380787","https://openalex.org/W3013397342","https://openalex.org/W3028675451","https://openalex.org/W3029441570","https://openalex.org/W3029953772","https://openalex.org/W3030461309","https://openalex.org/W3030898662","https://openalex.org/W3032636016","https://openalex.org/W3088588360","https://openalex.org/W4249731213","https://openalex.org/W4306702005"],"related_works":["https://openalex.org/W4398207996","https://openalex.org/W3158736337","https://openalex.org/W3048931162","https://openalex.org/W3088832985","https://openalex.org/W7214710757","https://openalex.org/W4391044448","https://openalex.org/W3112926233","https://openalex.org/W4238613245","https://openalex.org/W3196531415","https://openalex.org/W2911917895"],"abstract_inverted_index":{"Purpose:":[0],"Different":[1],"second-line":[2,65,263],"treatments":[3,108,179,211,264],"of":[4,35,63,261,285],"patients":[5],"with":[6,163,171],"trastuzumab-resistant":[7],"human":[8],"epidermal":[9],"growth":[10],"factor":[11],"receptor":[12],"2":[13,181],"(HER2)":[14],"positive":[15],"breast":[16,269],"cancer":[17],"were":[18,84],"examined":[19],"in":[20,109,180,212],"randomized":[21],"controlled":[22],"trials":[23],"(RCTs).A":[24],"network":[25,42,88,93],"meta-analysis":[26,43],"is":[27],"helpful":[28],"to":[29,51,99,160,237],"evaluate":[30],"the":[31,53,119,149,164,172,231,234,239,247,262,283],"comparative":[32],"survival":[33,56,60],"benefits":[34,62,147,198],"different":[36,64],"options.Methods:":[37],"We":[38],"performed":[39],"a":[40],"bayesian":[41],"using":[44],"R-4.0.0":[45],"software":[46],"and":[47,58,77,112,142,183,203,215,225,230,255,274,282],"fixed":[48],"consistency":[49],"model":[50],"compare":[52],"progression":[54],"free":[55],"(PFS)":[57],"overall":[59],"(OS)":[61],"regimens.Results:":[66],"13":[67],"RCTs":[68,79],"(19":[69],"publications,":[70,81],"4313":[71],"patients)":[72,83],"remained":[73],"for":[74,87,265,278],"qualitative":[75],"synthesis":[76],"12":[78],"(17":[80],"4022":[82],"deemed":[85],"eligible":[86],"meta-analysis.For":[89],"PFS,":[90],"we":[91,113,144,184,208],"divided":[92],"analysis":[94],"into":[95],"two":[96],"parts":[97],"owing":[98],"insufficient":[100],"connections":[101],"among":[102],"treatments.The":[103],"first":[104,150,232],"part":[105,176],"involved":[106],"8":[107,121],"9":[110],"studies":[111,182],"referred":[114,185],"it":[115,186],"as":[116,187],"PFS":[117,188,197],"(#1).Amid":[118],"following":[120],"interventions:":[122],"pyrotinib":[123,154],"+":[124,127,130,132,136,139,155,191,193,201,205,218,221,223],"capecitabine,":[125,133,137,140,143,224],"T-DM1":[126,217,226],"atezolizumab,":[128,219],"pertuzumab":[129,220],"trastuzumab":[131,135,192,200,222],"T-DM1,":[134],"lapatinib":[138],"neratinib,":[141],"found":[145],"consistent":[146],"between":[148],"three":[151],"interventions;":[152],"moreover,":[153],"capecitabine":[156,167,242],"was":[157,169],"most":[158],"likely":[159],"be":[161],"associated":[162,170],"best":[165],"benefits;":[166],"monotherapy":[168],"worst":[173,248],"PFS.The":[174],"second":[175],"included":[177],"3":[178],"(#2):":[189],"everolimus":[190],"vinorelbine":[194,202],"had":[195,227,233],"better":[196],"versus":[199],"afatinib":[204],"vinorelbine.For":[206],"OS,":[207],"analyzed":[209,256],"7":[210,213],"studies,":[214],"observed":[216],"similar":[228],"effectiveness,":[229],"highest":[235],"probability":[236],"yield":[238],"longest":[240],"OS;":[241],"or":[243],"neratinib":[244],"alone":[245],"yielded":[246],"OS":[249],"benefits.Conclusions:":[250],"Our":[251],"work":[252],"comprehensively":[253],"summarized":[254],"current":[257],"available":[258],"RCT-based":[259],"evidence":[260],"trastuzumab-treated,":[266],"HER2-positive,":[267],"advanced":[268],"cancer.These":[270],"results":[271],"provide":[272],"clinicians":[273],"oncologists":[275],"meaningful":[276],"references":[277],"clinical":[279],"drug":[280],"administration":[281],"development":[284],"novel":[286],"effective":[287],"therapies.":[288]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2021-02-15T00:00:00"}